Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DVS-233 SR and Venlafaxine ER in MDD
NCT00087737Phase 3Completed
- Sponsor
- Pfizer
- Primary completion
- May 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of desvenlafaxine in major depressive disorder (MDD), sponsored by Pfizer. Status: completed.
02
Drugs
desvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00087737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087737.